In one publication, elevated CDK11 protein expression in breast cancer tissues was associated with poor differentiation of tumor for breast cancer patients, but statistical significance was not achieved for survival at 72 months of follow-up [13]. This evidence concerns the gene CDK19 and neoplasm.